Skip to main content

C.R. Bard Wins First Bellwether Hernia Mesh Trial

C.R. Bard Wins First Bellwether Hernia Mesh Trial

C.R. Bard Wins First Bellwether Hernia Mesh Trial

Introduction

C.R. Bard has been awarded the first win in the Ventralight ST hernia mesh of Ohio, where the plaintiff accused that the company's product was defective and resulted in multiple injuries to him.

In 2015, the plaintiff got implanted the mesh to treat hernia, but soon he suffered pain and emotional distress due to the defective mesh products as per the allegations. Later, the plaintiff was required to undergo additional surgery to get the mesh removed, which was physically and mentally stressful for him.

As per the lawsuit, the plaintiff alleged that "ST" coating designed to "resorb" did not last for long as advertised by the company, which resulted in serious injuries. The lawsuit alleged the company of failing to inform the consumers about the design defects and risks associated with the products.

It is the first trial consolidated in the MDL formed in Ohio court in August 2018 against the company. On September 2, the court rejected the C.R. Bard’s pre-verdict motion, considering the evidence provided by the plaintiffs that highlight the dangers of the product to the patients.

U.S. District Judge Edmund A. Sargus, Jr. is overseeing all the product liability claims in the MDL formed in the Southern District of Ohio, where the company faces more than 8,000 lawsuits.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!